Turning Point Therapeutics, Inc. (TPTX) has 62 open-market insider trades by 20 insiders since 2006. The most active filer is Jingrong Jean Cui, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jingrong Jean Cui | Dir | — | 25 | $42.8M | 2020-06-09 |
| Simeon George | Dir | — | 3 | $18.8M | 2022-08-17 |
| Glaxosmithkline PLC | Dir | — | 3 | $18.8M | 2020-05-21 |
| Athena Countouriotis | CEOPres | — | 5 | $9.4M | 2022-08-17 |
| Annette North | CLOVP | — | 5 | $7.3M | 2022-02-09 |
| Cormorant Asset Management, LP | Dir10% Owner | — | 1 | $7.2M | 2019-05-14 |
| Brian Lee Baker | VP | — | 3 | $6.7M | 2021-03-23 |
| Carl L. Gordon | Dir | — | 1 | $6.5M | 2019-04-22 |
| Yi Larson | CFOVP | — | 2 | $3.9M | 2021-02-08 |
| Siegfried Reich | CSOVP | — | 2 | $3.7M | 2022-02-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Paolo Tombesi | CFO & VP | Sell | $177K | 2022-07-27 |
| Siegfried Reich | EVP & Chief Scientific Officer | Sell | $14K | 2022-02-09 |
| Mohammad Hirmand | EVP & Chief Medical Officer | Sell | $24K | 2022-02-09 |
| Athena Countouriotis | CEO & President | Sell | $216K | 2022-02-09 |
| Andrew John Partridge | EVP & Chief Commercial Officer | Sell | $8K | 2022-02-09 |
| Annette North | CLO & VP | Sell | $800K |
Companies that share insiders with TPTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-08-30 |
| Andrew John Partridge | CCO & VP | Sell | $280K | 2021-07-14 |
| Mark J. Alles | Director | Buy | $163K | 2021-06-21 |
| Annette North | CLO & VP | Sell | $2.1M | 2021-06-15 |
| Brian Lee Baker | VP | Sell | $5.7M | 2021-03-23 |
| Annette North | CLO & VP | Sell | $4.3M | 2021-03-08 |
| Siegfried Reich | CSO & VP | Sell | $6.5M | 2021-03-04 |
| Athena Countouriotis | CEO & President | Sell | $15.6M | 2021-02-09 |
| Yi Larson | CFO & VP | Sell | $7.4M | 2021-02-01 |
| Annette North | CLO & VP | Sell | $5.7M | 2021-02-01 |